Endra Life Sciences Inc Expected To Post A Loss Of 27 Cents A Share: Earnings Preview

ENDRA Life Sciences

10/05/2024 22:35

* ENDRA Life Sciences Inc  NDRA.OQ   NDRA.O  is expected
to show
no change in quarterly revenue when it reports  results on May
14 for the period ending March 31 2024
    * 
    * ​LSEG's mean analyst estimate for ENDRA Life Sciences Inc
is for
a loss of 27 cents per share. 
    * The one available analyst rating on the shares is "buy".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for ENDRA Life
Sciences Inc is $10.00​, above​ its last closing price of $0.30.
​​​

This summary was machine generated May 10 at 21:35 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)